

Publisher: Bentham Science Publishers
E-ISSN: 1875-628x|11|7|922-929
ISSN: 1570-1808
Source: Letters in Drug Design & Discovery, Vol.11, Iss.7, 2014-08, pp. : 922-929
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Piroxicam-&bgr;-Cyclodextrin: A GI Safer Piroxicam
Current Medicinal Chemistry, Vol. 20, Iss. 19, 2013-06 ,pp. :





